Regenxbio (RGNX) Return on Sales (2016 - 2025)
Historic Return on Sales for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to 2.08%.
- Regenxbio's Return on Sales rose 3800.0% to 2.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.1%, marking a year-over-year increase of 17300.0%. This contributed to the annual value of 2.73% for FY2024, which is 1900.0% up from last year.
- As of Q3 2025, Regenxbio's Return on Sales stood at 2.08%, which was up 3800.0% from 3.32% recorded in Q2 2025.
- In the past 5 years, Regenxbio's Return on Sales ranged from a high of 0.74% in Q4 2021 and a low of 4.06% during Q1 2024
- In the last 5 years, Regenxbio's Return on Sales had a median value of 2.46% in 2024 and averaged 2.39%.
- As far as peak fluctuations go, Regenxbio's Return on Sales crashed by -26500bps in 2022, and later skyrocketed by 41200bps in 2025.
- Regenxbio's Return on Sales (Quarter) stood at 0.74% in 2021, then crashed by -359bps to 1.91% in 2022, then tumbled by -48bps to 2.84% in 2023, then grew by 15bps to 2.42% in 2024, then increased by 14bps to 2.08% in 2025.
- Its Return on Sales stands at 2.08% for Q3 2025, versus 3.32% for Q2 2025 and 0.07% for Q1 2025.